Strata Critical Medical, Inc. (SRTA) stock
SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3037% below fair value
$5.51−0.26 (-4.51%)
Close on Nov 13, 2026Market cap $487.45MP/E 10.8Yield –
Strata Critical Medical cash
Cash and short-term investments held at the end of each period.
Strata Critical Medical's cash was $22.75M at Jun 30, 2026. For fiscal 2025 it was $61.50M, down 52.1% from the year before. The highest annual figure on record is $304.13M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.50M | -52.1% |
| FY2024 | Dec 31, 2024 | $128.40M | -23.2% |
| FY2023 | Dec 31, 2023 | $167.29M | -45.0% |
| FY2021 | Sep 30, 2021 | $304.13M | +2377.4% |
| FY2020 | Sep 30, 2020 | $12.28M | -44.6% |
| FY2019 | Sep 30, 2019 | $22.18M | -33.9% |
| FY2018 | Sep 30, 2018 | $33.53M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $22.75M | -79.9% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $58.79M | -51.0% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $61.50M | -52.1% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $75.92M | -44.3% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $113.42M | -20.1% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $120.01M | -20.5% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $128.40M | -23.2% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $136.34M | -21.3% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $141.95M | -16.3% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $150.97M | -14.7% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $167.29M | -45.0% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $173.23M | -48.0% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $169.69M | +2159.2% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $176.95M | +1341.4% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $304.13M | +2230.7% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $333.17M | +30372.5% |
| Q1 FY2021CQ4 2020 | Mar 31, 2021 | $7.51M | -66.1% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $12.28M | -63.4% |
| Q2 FY2020CQ1 2020 | Jun 30, 2020 | $13.05M | – |
| Q1 FY2020CQ4 2019 | Mar 31, 2020 | $1.09M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $22.18M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $33.53M | – |
See a number that looks wrong?